79 related articles for article (PubMed ID: 22497255)
1. Genotyping of -374A/T, -429A/G, and 63 bp Ins/del polymorphisms of RAGE by rapid one-step hexaprimer amplification refractory mutation system polymerase chain reaction in breast cancer patients.
Hashemi M; Moazeni-Roodi A; Arbabi F; Fazaeli A; Nasab EE; Taheri M; Kerkhoff C; Ghavami S
Nucleosides Nucleotides Nucleic Acids; 2012 May; 31(5):401-10. PubMed ID: 22497255
[TBL] [Abstract][Full Text] [Related]
2. Bi-directional PCR allele-specific amplification (bi-PASA) for detection of caspase-8 -652 6N ins/del promoter polymorphism (rs3834129) in breast cancer.
Hashemi M; Eskandari-Nasab E; Fazaeli A; Rezaei H; Mashhadi MA; Arbabi F; Taheri M
Gene; 2012 Aug; 505(1):176-9. PubMed ID: 22659694
[TBL] [Abstract][Full Text] [Related]
3. The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes.
Kirbis J; Milutinović A; Steblovnik K; Teran N; Terzić R; Zorc M
Coll Antropol; 2004 Dec; 28(2):611-6. PubMed ID: 15666591
[TBL] [Abstract][Full Text] [Related]
4. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
[TBL] [Abstract][Full Text] [Related]
5. Association analysis of -429T/C and -374T/A polymorphisms of receptor of advanced glycation end products (RAGE) gene in Malaysian with type 2 diabetic retinopathy.
Ng ZX; Kuppusamy UR; Tajunisah I; Fong KC; Chua KH
Diabetes Res Clin Pract; 2012 Mar; 95(3):372-7. PubMed ID: 22154374
[TBL] [Abstract][Full Text] [Related]
6. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
Hu Z; Li X; Yuan R; Ring BZ; Su L
Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.
Kalousová M; Jáchymová M; Germanová A; Kubena AA; Tesar V; Zima T
Kidney Blood Press Res; 2010; 33(1):30-6. PubMed ID: 20185929
[TBL] [Abstract][Full Text] [Related]
8. The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.
Däbritz J; Friedrichs F; Weinhage T; Hampe J; Kucharzik T; Lügering A; Broeckel U; Schreiber S; Spieker T; Stoll M; Foell D
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G823-32. PubMed ID: 21311028
[TBL] [Abstract][Full Text] [Related]
9. Application of Single-Tube Tri-Primer ARMS-PCR to Detect the NFKB1 ATTG Insertion/Deletion Polymorphism.
Chao J; Chai L; Yin X; Zhou Z; Xu S; Zhu W; Deng Y
Genet Test Mol Biomarkers; 2018 Jul; 22(7):443-447. PubMed ID: 30020835
[TBL] [Abstract][Full Text] [Related]
10. DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil.
Dufloth RM; Costa S; Schmitt F; Zeferino LC
Genet Mol Res; 2005 Dec; 4(4):771-82. PubMed ID: 16475125
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphisms (G82S, 1704G/T, 2184A/G and 2245G/A) of the receptor of advanced glycation end products (RAGE) in plaque psoriasis.
Vasků V; Kanková K; Vasků A; Muzík J; Izakovicová Hollá L; Semrádová V; Vácha J
Arch Dermatol Res; 2002 May; 294(3):127-30. PubMed ID: 12029499
[TBL] [Abstract][Full Text] [Related]
12. The association of CYP2D6 *10 polymorphism with breast cancer risk and clinico-pathologic characteristics in Chinese women.
Li H; Feng L; Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Li J; Xie Y
Acta Oncol; 2006; 45(5):597-601. PubMed ID: 16864175
[TBL] [Abstract][Full Text] [Related]
13. Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features.
Marques D; Ferreira-Costa LR; Ferreira-Costa LL; Correa RDS; Borges AMP; Ito FR; Ramos CCO; Bortolin RH; Luchessi AD; Ribeiro-Dos-Santos Â; Santos S; Silbiger VN
World J Gastroenterol; 2017 Oct; 23(37):6854-6867. PubMed ID: 29085228
[TBL] [Abstract][Full Text] [Related]
14. Detection of a 4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 Using Mismatch PCR-RFLP and Its Association with Susceptibility to Breast Cancer.
Hashemi M; Danesh H; Bizhani F; Sattarifard H; Hashemi SM; Bahari G
Asian Pac J Cancer Prev; 2018 Apr; 19(4):923-926. PubMed ID: 29693343
[TBL] [Abstract][Full Text] [Related]
15. Combination of polymorphisms within 5' and 3' untranslated regions of thymidylate synthase gene modulates survival in 5 fluorouracil-treated colorectal cancer patients.
Fernández-Contreras ME; Sánchez-Hernández JJ; González E; Herráez B; Domínguez I; Lozano M; García De Paredes ML; Muñoz A; Gamallo C
Int J Oncol; 2009 Jan; 34(1):219-29. PubMed ID: 19082493
[TBL] [Abstract][Full Text] [Related]
16. Soluble receptor for advanced glycation end-products (sRAGE) and polymorphisms of RAGE and glyoxalase I genes in patients with pancreas cancer.
Krechler T; Jáchymová M; Mestek O; Zák A; Zima T; Kalousová M
Clin Biochem; 2010 Jul; 43(10-11):882-6. PubMed ID: 20398646
[TBL] [Abstract][Full Text] [Related]
17. Rapid analysis of XRCC1 polymorphisms using real-time polymerase chain reaction.
Schneider J; Classen V; Philipp M; Helmig S
Mol Cell Probes; 2006; 20(3-4):259-62. PubMed ID: 16542819
[TBL] [Abstract][Full Text] [Related]
18. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
[TBL] [Abstract][Full Text] [Related]
19. Improvement in ACE I/D polymorphism detection.
Bolli P; Sticchi E; Giusti B; Saracini C; Abbate R; Fatini C
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):129-32. PubMed ID: 21059823
[TBL] [Abstract][Full Text] [Related]
20. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
Smith KC; Bateman AC; Fussell HM; Howell WM
Eur J Immunogenet; 2004 Aug; 31(4):167-73. PubMed ID: 15265021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
